ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM

Founder, ETFguide • Oct 21, 2021 at 4:00 PM EDT

The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.

Image Source: Pixabay

In this episode of ETF Battles, you'll watch an audience-requested triple-header between the ARK Genomic Revolution ETF (ARKG), Global X Genomics & Biotechnology ETF (GNOM), and iShares Genomics Immunology & Healthcare ETF (IDNA). The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.

Video Length: 00:18:45

Disclaimer:

Ron DeLegge has analyzed and graded more than $125 million with his Portfolio Report Card grading system. Does your portfolio pass or fail? Find out and if you get an "A" Ron will pay you $100.